Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist illustration of a virus and cell in dark colors with lime accents.

May 30, 2026

OpenAI is giving away its life sciences AI model to help governments prepare for the next pandemic

OpenAI has initiated the Rosalind Biodefense program, providing access to its advanced life sciences AI model, GPT-Rosalind, to select developers and government partners. This initiative aims to enhance biodefense and pandemic preparedness by facilitating faster transitions from hypothesis to experimentation in research.The program responds to ongoing concerns regarding the potential misuse of AI in bioweapons and seeks to bolster the capabilities of researchers in diagnostics, early warning sys
A syringe and vaccine vial on a wooden table in a medical office setting.

May 30, 2026

OpenAI launches Rosalind Biodefense, offers federal agencies early access to its life-sciences model

OpenAI has introduced Rosalind Biodefense, a program designed to enhance pandemic preparedness and biosecurity through its GPT-Rosalind life-sciences model. This initiative allows selected developers and U.S. government agencies to access the model for creating tools aimed at public health and biodefense.The program features two main tracks: one for developers and another for government agencies. The developer track enables vetted outside developers to utilize GPT-Rosalind for building tools rel
A minimalist illustration of a pill and a dollar sign representing biotech investment.

May 30, 2026

Some investors are turning to biotech as a hedge against potential AI bubbles

Investors are increasingly shifting their focus back to the biopharma sector as a strategic hedge against potential instability in the AI market.Recent trends indicate that various investment groups, including crossover investors and hedge funds, are rebalancing portfolios that have heavily favored AI. Kevin Eisele from William Blair noted that the significant weight of tech and AI companies in major indices has prompted a reevaluation, leading to renewed interest in biopharma investments. This
A human silhouette and gear representing biotech innovation

May 29, 2026

From Retail to Biotech: The Human Stories Behind America’s Tech Revolution

The article discusses the intersection of technology and life sciences, highlighting the human stories behind advancements in AI and biotechnology.Experts emphasize the importance of investing in individuals—students, veterans, and professionals—who are pivotal in the U.S. technology landscape, particularly during Service to Nation's Apprenticeship week. Christine Burkette, a former research chemist, outlined how skills from military logistics can be effectively applied in various industries, no
A tissue sample on a glass slide under a microscope in a clinical lab setting.

May 29, 2026

TEM: AI-powered diagnostics and data platform drives rapid growth and pharma partnerships

Recent developments highlight the rapid expansion of an AI-driven healthcare platform that now serves over 5,000 U.S. institutions, offering a wide range of diagnostics and data applications. This platform's growth is significantly influenced by recent FDA approvals, which have bolstered its diagnostic capabilities. Additionally, the integration of advanced algorithms has enhanced its data analytics, making it a valuable resource for healthcare providers. The business is further accelerating t
A technician adjusting a circuit board with a screwdriver on a workbench.

May 29, 2026

Nordic Introduces AI-Assisted IoT Development Platform

Nordic Semiconductor has launched an innovative AI-assisted development framework aimed at enhancing the lifecycle management of wireless IoT devices.This new platform is notable for being the first in the wireless IoT sector to integrate AI-driven workflows that span hardware, software, and cloud services within a cohesive development environment. The framework is designed to simplify the embedded development process by consolidating firmware creation, device deployment, and field diagnostics i
Silhouette of a generic medicine bottle representing pharmaceutical trust

May 29, 2026

"Importance of India is now": US envoy Sergio Gor highlights Pharma trust, Pax Silica partnership

US Ambassador Sergio Gor has underscored the pivotal role of India in the global pharmaceutical landscape and technology partnerships, particularly through the Pax Silica initiative. This highlights a growing trust between the nations as they collaborate on critical supply chains and future technologies.During the US-India TRUST Initiative event at IIT Delhi, Gor emphasized India's significant contribution to the pharmaceutical sector, noting that around 40% of generic medicines in the U.S. are
A minimalist representation of cloud technology in life sciences.

May 29, 2026

Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise?

The life sciences technology sector is rapidly evolving, driven by the increasing adoption of cloud-based software and AI by pharmaceutical and biotech companies. This transformation is reflected in the projected growth of the global life sciences IT market, which is expected to reach $62.5 billion by 2033. Amid this landscape, Veeva Systems and IQVIA stand out as key players, each with distinct business models addressing the industry's needs.Veeva Systems has solidified its position in life sci
A stethoscope on a desk next to an open patient record in a clinical office.

May 29, 2026

Infosys Acquires Optimum Healthcare to Strengthen Digital Healthcare Transformation Capabilities

Infosys has acquired Optimum Healthcare IT, aiming to enhance its digital transformation capabilities in the healthcare sector.This acquisition, valued at approximately $465 million, aligns with Infosys’ strategy to expand its influence within the healthcare provider segment, particularly in the U.S. market. By integrating Optimum’s expertise, Infosys plans to bolster its existing platforms, such as Infosys Topaz and Infosys Cobalt, to facilitate comprehensive cloud and data transformation initi
A minimalist representation of a contract with a checkmark, symbolizing successful agreements in AI commercialization.

May 29, 2026

Global AI Reports Fiscal Year 2025 Results; Successfully Commercializes Agentic AI Platform with Large Enterprise Customers Across Multiple Industries

Global AI Inc. has reported significant growth in fiscal year 2025, driven by the successful commercialization of its Agentic AI Platform across various sectors, including pharmaceuticals and insurance.For the fiscal year ending December 31, 2025, Global AI Inc. saw a staggering revenue increase of 477.8%, reaching $143,838, compared to $24,896 in the previous year. Gross profit also rose significantly by 343.8%. The company launched its Agentic AI Platform in December 2025, securing contracts w
A radioconjugate vial on a lab bench in a clinical setting.

May 29, 2026

Nucs AI Announces Collaboration to Develop AI-driven Response Prediction for Next-Generation Therapeutic Radioconjugates

Nucs AI has partnered with AstraZeneca to enhance predictive imaging biomarkers for therapeutic radioconjugates, specifically targeting metastatic prostate cancer.This collaboration marks a significant step in the pharmaceutical industry's exploration of AI-driven response prediction models. Nucs AI aims to adapt its existing technology to create predictive models tailored for next-generation PSMA-targeted radioconjugates. By focusing on metastatic castration-resistant prostate cancer, the partn
A stethoscope on a wooden desk in a dimly lit clinic room, with a glowing lamp and medical chart in the background.

May 29, 2026

Why Digital Health Is Becoming One of the Fastest-Growing Sectors for Business Investment in 2026

The digital health sector is rapidly transforming, emerging as a leading area for business investment as we approach 2026.Traditionally viewed as a slow adopter of technology, healthcare is now experiencing a significant shift. The pressures of rising administrative costs, a shortage of clinical staff, and increasing patient demand are prompting healthcare providers, insurers, and investors to invest heavily in digital health solutions. This transition is marked by a growing recognition that dig